Management of Pancreatic Insufficiency

Core Treatment: Pancreatic Enzyme Replacement Therapy (PERT)

The American Gastroenterological Association recommends initiating pancreatic enzyme replacement therapy (PERT) immediately upon diagnosis with at least 40,000 USP units of lipase per meal in adults, taken during meals, combined with routine fat-soluble vitamin supplementation and regular nutritional monitoring 1, 2
Adults and children ≥4 years should start with an initial dose of 40,000-50,000 USP units of lipase per main meal, and 20,000 USP units of lipase for snacks, which is half the meal dose 1, 2, 3
PERT must be taken during the meal, not before or after, to maximize mixing with nutrients and optimize digestion, as recommended by the American Gastroenterological Association 1, 3, 4
All FDA-approved PERT formulations are porcine-derived and equally effective at equivalent lipase doses, including Creon, Zenpep, Pancreaze, Pertzye, and Viokace, according to the American Gastroenterological Association 1, 2, 3, 4

Routine supplementation and monitoring of vitamins A, D, E, and K are required, with vitamin K dosing ranging from 0.3-1 mg/day for infants to 1-10 mg/day for older children and adults, as recommended by the American Gastroenterological Association and the Clinical Nutrition society 1, 2, 8, 9
A low-moderate fat diet with frequent smaller meals is recommended, while avoiding very-low-fat diets, which are counterproductive, according to the American Gastroenterological Association 1, 2, 8

Infants should be monitored for growth and nutritional status at every clinic visit, while children and adolescents should be assessed every 3 months, and adults every 6 months for stable patients, as recommended by the Clinical Nutrition society and the American Gastroenterological Association 5, 6, 3
Baseline and serial measurements should include body mass index, fat-soluble vitamin levels, quality-of-life assessment, and dual-energy x-ray absorptiometry (DEXA) scan, which should be repeated every 1-2 years, according to the American Gastroenterological Association 1, 8
Ongoing monitoring should include anthropometric measurements, serum markers, and hemoglobin A1c for diabetes screening, as recommended by the American Gastroenterological Association 3

Effective PERT produces reduction in steatorrhea and gastrointestinal symptoms, weight gain, improved muscle mass and function, and normalization of fat-soluble vitamin levels, according to the American Gastroenterological Association 1, 2, 8

Untreated pancreatic insufficiency leads to complications from fat malabsorption and malnutrition, negatively impacting quality of life and increasing mortality, as stated by the American Gastroenterological Association 1, 2
In pancreatic cancer patients, exocrine pancreatic insufficiency (EPI) reduces survival and ability to tolerate oncologic therapy, according to the American Gastroenterological Association 4